These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4389812)

  • 1. [Inhibition of monoamine oxidase and diamine oxidase by furazolidone (Furoxon). Pharmacologic and biochemical studies in man].
    Palm D; Magnus U
    Klin Wochenschr; 1968 Jul; 46(13):720-8. PubMed ID: 4389812
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of monoamine oxidase in man by furazolidone.
    Pettinger WA; Soyangco FG; Oates JA
    Clin Pharmacol Ther; 1968; 9(4):442-7. PubMed ID: 5655478
    [No Abstract]   [Full Text] [Related]  

  • 3. The anti-diamine oxidase effect of furazolidone in rabbits.
    Ali BH
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1983; 74(1):109-10. PubMed ID: 6132752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibition of monoamine oxidase by bacteriostatically active nitrofuran derivatives].
    Palm D; Magnus U; Grobecker H; Jonsson J
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 256(2):281-300. PubMed ID: 4233003
    [No Abstract]   [Full Text] [Related]  

  • 5. Human kidney diamine oxidase: inhibition studies.
    Shindler JS; Bardsley WG
    Biochem Pharmacol; 1976 Dec; 25(24):2689-94. PubMed ID: 827296
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoamine oxidase inhibitors and other drugs as inhibitors of diamine oxidase from human placenta and pig kidney.
    Crabbe MJ; Bardsley WG
    Biochem Pharmacol; 1974 Nov; 23(21):2983-900. PubMed ID: 4215424
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of monoamine oxidase by furazolidone in germfree rats.
    Yeung TC; Goldman P
    Biochem Pharmacol; 1981 Sep; 30(17):2496-7. PubMed ID: 21043255
    [No Abstract]   [Full Text] [Related]  

  • 8. Debrisoquin, a selective inhibitor of intraneuronal monoamine oxidase in man.
    Pettinger WA; Korn A; Spiegel H; Solomon HM; Pocelinko R; Abrams WB
    Clin Pharmacol Ther; 1969; 10(5):667-74. PubMed ID: 5808462
    [No Abstract]   [Full Text] [Related]  

  • 9. Action of inhibitors on monoamine and diamine metabolism in the rat.
    Sourkes TL; Missala K
    Can J Biochem; 1977 Jan; 55(1):56-9. PubMed ID: 402175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On the mechanism of toxic effect of triethylamine].
    Chernen'kiĭ IK
    Farmakol Toksikol; 1968; 31(6):750-2. PubMed ID: 4388891
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of monoamine oxidase in chickens and ducklings by a microbial metabolite of furazolidone.
    Ali BH; Bartlet AL
    Q J Exp Physiol; 1982 Jan; 67(1):69-79. PubMed ID: 7079451
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of rat fat cell lipolysis by monoamine oxidase and semicarbazide-sensitive amine oxidase substrates.
    Visentin V; Prévot D; Marti L; Carpéné C
    Eur J Pharmacol; 2003 Apr; 466(3):235-43. PubMed ID: 12694806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a furazolidone metabolite responsible for the inhibition of amino oxidases.
    Timperio AM; Kuiper HA; Zolla L
    Xenobiotica; 2003 Feb; 33(2):153-67. PubMed ID: 12623758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supersensitivity to tyramine during monoamine oxidase inhibition in man. Mechanism at the level of the adrenergic neuron.
    Pettinger WA; Oates JA
    Clin Pharmacol Ther; 1968; 9(3):341-4. PubMed ID: 5649986
    [No Abstract]   [Full Text] [Related]  

  • 15. Monoacylcadaverines as substrates for both monoamine oxidase and diamine oxidase; low rates of activity.
    Suzuki O; Matsumoto T; Oya M; Katsumata Y; Stepita-Klauco M
    Experientia; 1980 May; 36(5):535-7. PubMed ID: 6769699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between sympathomimetic amines and a new monoamine oxidase inhibitor.
    Lader MH; Sakalis G; Tansella M
    Psychopharmacologia; 1970 Aug; 18(1):118-23. PubMed ID: 4943186
    [No Abstract]   [Full Text] [Related]  

  • 17. HPLC-UV assays for evaluation of inhibitors of mono and diamine oxidases using novel phenyltetrazolylalkanamine substrates.
    Mergemeier K; Lehr M
    Anal Biochem; 2018 May; 549():29-38. PubMed ID: 29550344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose handling in streptozotocin-induced diabetic rats is improved by tyramine but not by the amine oxidase inhibitor semicarbazide.
    Visentin V; Bour S; Boucher J; Prévot D; Valet P; Ordener C; Parini A; Carpéné C
    Eur J Pharmacol; 2005 Oct; 522(1-3):139-46. PubMed ID: 16202994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development of drugs for neuropsychiatric disorders?
    Baker GB; Sowa B; Todd KG
    J Psychiatry Neurosci; 2007 Sep; 32(5):313-5. PubMed ID: 17823646
    [No Abstract]   [Full Text] [Related]  

  • 20. Proceedings: Diamine oxidase in the small intestine of rabbits: separation from a soluble monoaminoxidase and alteration of the activity by intestinal ischemia.
    Kusche J; Richter H; Friedrich A; Schmidt J; Hesterberg R; Lorenz W
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R53. PubMed ID: 4276595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.